Pharma Law is a leading life sciences and pharmaceutical legal and compliance consultancy with more than 20 years commercial strategy and 'top 20 big pharma' experience, providing flexible specialist legal, compliance, regulatory and commercial strategy services in the Life Science and Pharmaceutical sectors.
At Pharma Law, we know the A to Z of your industry like the back of our hands. Providing practical 'end to end' legal and compliance Services and Solutions
from early clinical development through to end of life cycle management for multi billion blockbuster products facing patent expiry, and every step in between:
- Advertising, Marketing & Promotion
- Anti-corruption
- Anti-trust & Competition Law
- Alliances, Collaborations & Joint Working
- Clinical Research, IIS & Post-MA studies
- Codes of Practice & Regulatory Disputes
- Commercial Contracting & Procurement
- Compliance & Ethics
- Corporate Policies & Procedures
- Data Privacy & GDPR
- Digital Communications & Social Media
- Disputes: ASA, Contracting, PMCPA
- Document Drafting, Review and Approval
- Events, Conferences & Congress
- HCP, HCO & Professional Services
- Homecare Delivery & Patient Services
- Intellectual Property
- Market Access, Pricing & Reimbursement
- Meetings & Hospitality
- Merger, Acquisition and Divestment Patient
- Patient Advocacy and Patient Organisations
- Publications & Professional Endorsement
- Scientific Services & Ad Boards
- Sponsorship, Grants & Donations
- Wholesale, Distribution, Warehousing & Logistics
Within the past decade, our consultants have
personally managed
the legal affairs for
7 of the 'top 20' 2019 global blockbuster pharmaceutical products*
for the UK & Ireland markets, helped facilitate market entry for novel products in in CV, Immunology and Oncology, with many therapy line extensions, pricing and reimbursement, and managed patent expiry for blockbusters in CV, Respiratory, Immunology:
- Arthritis, AS, UC, Crohns, Psoriasis adalimumab
- Neovascular (wet) Age-related Macular
Degeneration aflibercept
- Stroke and Systemic Embolism riveroxaban, apixaban and dabigatran
- NTRK gene fusion- positive solid tumours larotrectinib
- Androgen-receptor inhibitor darolutamide
- Melanoma
nivolumab
- HIV bictegravir/emtricitabine/tenofovir alafenamide, emtricitabine and tenofovir alafenamide and elvitegravir, cobicistant, emtricitabine and tenofovir alafenamide fumarate
- COPD and Asthma tiotropium bromide
- Parkinsons pramipexole and intestinal levadopa / carbidopa
- Multiple Sclerosis delta-9-tetrahydrocannibinol and cannabidiol
* https://www.fiercepharma.com/special-report/top-20-drugs-by-global-sales-2019
Whether its a simple NDA to a complex restructuring, 1 day a week support or full outsourcing service, we can help.